Revelation Biosciences, Inc. REVB
4.36 USD +0.42 (+10.66%)
At closeNov 12, 2026, 4:06 AM EST
4.36 0.00 0.00%
Pre-market · Nov 12, 4:06 AM ET
3.92 Day range 4.36
3.08 52-week range 40.60
- YTD
- +36.25%
- 1 year
- +10.94%
News
benzinga.com Revelation Biosciences Q3 EPS $(5.92) Beats $(6.16) Estimate Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(5.92) per share which beat the analyst consensus estimate of $(6.16) by 3.9 percent. This is a 88.04 percent increase over losses…
businesswire.com Revelation Biosciences, Inc. Announces Financial Results For the Three and Nine Months Ended September 30, 2026 SAN DIEGO--(BUSINESS WIRE)---- $REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company developing innovative solutions to treat…benzinga.com Revelation Biosciences Announces 1-For-7 Reverse Stock Split, Effective Oct. 20 Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, announced today
